Search

everythinglearnresearchcommunity

for

Search:↓

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Retinoids may help treat lupus nephritis and reduce steroid use.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

JAK inhibitors show promise for treating Alopecia Areata, while statins are not recommended.

Women are more likely to have long-term post-COVID symptoms than men.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Generic drug inserts in Saudi Arabia often have inaccurate information, needing better regulation and quality control.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.